Google introduced Gemini Spark, a new AI agent designed to handle multistep tasks across its services. The tool was shown during a demo at the company's developer event.
Google presented Gemini Spark on Tuesday at its Google I/O developer conference. In the demonstration the agent managed tasks such as planning a block party by counting RSVPs, sending follow-ups and maintaining an automatic tracker linked to Gmail.
Reported by AI Image generated by AI
Google is rolling out its Gemini AI model more widely, with new features for smart home devices and on-device use in Chrome.
Google introduced several new AI features during its I/O 2026 developer conference this week in Mountain View, California. The updates center on an enhanced search experience and a new autonomous assistant called Gemini Spark.
Reported by AI
Google unveiled a wave of AI-driven updates for Android devices and introduced Googlebooks, a new line of laptops, during its Android Show presentation on Tuesday. The announcements focus on proactive AI features through Gemini Intelligence and enhanced integration across phones, cars and computers.
Google has begun rolling out a new 'Skills' feature in its Chrome browser on desktop, enabling users to save and quickly reuse custom Gemini AI prompts. The update makes it easier to repeat tasks like calculating protein in recipes or comparing products across tabs. Skills sync across devices when signed into a Google account and include a library of premade prompts.
Reported by AI
Google has introduced a new command-line interface tool for its Workspace suite, aimed at simplifying integration with AI systems like OpenClaw. The tool bundles APIs from products such as Gmail, Drive, and Calendar, though it is not an officially supported product. This release emphasizes ease of use for both human developers and AI agents.
Demis Hassabis highlighted Google's work using artificial intelligence to advance medical treatments during a recent keynote address. The CEO of Google DeepMind and Isomorphic Labs focused on projects targeting cancer and immune disorders.